• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素聚糖链表征:细菌消除酶肝素裂解酶 III 和细菌水解酶 Bp 对大肠杆菌 K5 肝素聚糖的顺序解聚,以制备定义明确的低聚物。

Heparosan Chain Characterization: Sequential Depolymerization of E. Coli K5 Heparosan by a Bacterial Eliminase Heparin Lyase III and a Bacterial Hydrolase Heparanase Bp to Prepare Defined Oligomers.

机构信息

Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

出版信息

Biotechnol J. 2021 Mar;16(3):e2000336. doi: 10.1002/biot.202000336. Epub 2020 Nov 10.

DOI:10.1002/biot.202000336
PMID:33006278
Abstract

Heparosan is a non-sulfated polysaccharide and potential applications include, chemoenzymatic synthesis of heparin and heparan sulfates. Heparosan is produced using microbial cells (natural producers or engineered cells). The characterization of heparosan isolated from both natural producers and engineered-cells are critical steps towards the potential applications of heparosan. Heparosan is characterized using 1) analysis of intact chain size and polydispersity, and 2) disaccharide composition. The current paper describes a novel method for heparosan chain characterization, using heparin lyase III (Hep-3, an eliminase from Flavobacterium heparinum) and heparanase Bp (Hep-Bp, a hydrolase from Burkholderia pseudomallei). The partial digestion of E. coli K5 heparosan with purified His-tagged Hep-3 results in oligomers of defined sizes. The oligomers (degree of polymerization from 2 to 8, DP2-DP8) are completely digested with purified GST-tagged Hep-Bp and analyzed using gel permeation chromatography. Hep-Bp specifically cleaves the linkage between d-glucuronic acid (GlcA) and N-acetyl-d-glucosamine (GlcNAc) but not the linkage between 4-deoxy-α-L-threo-hex-4-enopyranosyluronic acid (deltaUA) and GlcNAc, and results in the presence of a minor resistant trisaccharide (GlcNAc-GlcA-GlcNAc). This method successfully demonstrated the substrate selectivity of Hep-BP on heparosan oligomers. This analytical tool could be applied towards heparosan chain mapping and analysis of unnatural sugar moieties in the heparosan chain.

摘要

肝素聚糖是一种非硫酸化多糖,其潜在应用包括肝素和硫酸乙酰肝素的化学酶合成。肝素聚糖是利用微生物细胞(天然生产者或工程细胞)生产的。从天然生产者和工程细胞中分离出的肝素聚糖的特性分析是实现肝素聚糖潜在应用的关键步骤。肝素聚糖的特性可以通过以下两种方法进行分析:1)完整链大小和多分散性的分析,以及 2)二糖组成的分析。本文描述了一种新的肝素聚糖链特性分析方法,使用肝素酶 III(Hep-3,来自Flavobacterium heparinum 的消除酶)和肝素酶 Bp(Hep-Bp,来自Burkholderia pseudomallei 的水解酶)。用纯化的 His 标记的 Hep-3 部分消化 E. coli K5 肝素聚糖会产生具有确定大小的低聚物。这些低聚物(聚合度从 2 到 8,DP2-DP8)被纯化的 GST 标记的 Hep-Bp 完全消化,并使用凝胶渗透色谱进行分析。Hep-Bp 特异性地切割 d-葡萄糖醛酸(GlcA)和 N-乙酰-d-葡萄糖胺(GlcNAc)之间的键,但不切割 4-去氧-α-L-赤式-己-4-烯吡喃糖醛酸(deltaUA)和 GlcNAc 之间的键,导致存在少量抗性三糖(GlcNAc-GlcA-GlcNAc)。该方法成功地证明了 Hep-BP 在肝素聚糖低聚物上的底物选择性。这种分析工具可应用于肝素聚糖链的作图分析和肝素聚糖链中不天然糖基的分析。

相似文献

1
Heparosan Chain Characterization: Sequential Depolymerization of E. Coli K5 Heparosan by a Bacterial Eliminase Heparin Lyase III and a Bacterial Hydrolase Heparanase Bp to Prepare Defined Oligomers.肝素聚糖链表征:细菌消除酶肝素裂解酶 III 和细菌水解酶 Bp 对大肠杆菌 K5 肝素聚糖的顺序解聚,以制备定义明确的低聚物。
Biotechnol J. 2021 Mar;16(3):e2000336. doi: 10.1002/biot.202000336. Epub 2020 Nov 10.
2
Production of a low molecular weight heparin using recombinant glycuronidase [corrected].使用重组糖醛酸酶生产低分子量肝素[已纠正]。
Carbohydr Polym. 2015 Dec 10;134:151-7. doi: 10.1016/j.carbpol.2015.08.001. Epub 2015 Aug 6.
3
Quantitation of heparosan with heparin lyase III and spectrophotometry.肝素酶 III 和分光光度法定量硫酸乙酰肝素。
Anal Biochem. 2014 Feb 15;447:46-8. doi: 10.1016/j.ab.2013.10.029. Epub 2013 Oct 30.
4
High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.益生菌大肠杆菌Nissle 1917用于透明质酸生产、表征及修饰的高密度发酵
Appl Microbiol Biotechnol. 2021 Feb;105(3):1051-1062. doi: 10.1007/s00253-020-11079-9. Epub 2021 Jan 22.
5
Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III.葡萄糖胺 - 葡萄糖醛酸和N - 乙酰葡萄糖胺 - 葡萄糖醛酸键对肝素酶III的相对敏感性。
Biochemistry. 2004 Jul 6;43(26):8590-9. doi: 10.1021/bi036250k.
6
New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.通过使用来自大肠杆菌的K5多糖和2-O-去硫酸化肝素的合成衍生物揭示了来自肝素黄杆菌的肝素和硫酸乙酰肝素裂解酶特异性的新见解。
Glycoconj J. 1999 Jun;16(6):265-70. doi: 10.1023/a:1007057826179.
7
Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides.用于控制生产低分子量肝素聚糖和特定大小肝素聚糖寡糖的非致病性大肠杆菌菌株的代谢工程。
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129765. doi: 10.1016/j.bbagen.2020.129765. Epub 2020 Oct 16.
8
Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase.用肝素酶或肝素裂合酶解聚的 N-硫酸乙酰肝素进行低分子量肝素的酶法合成。
Carbohydr Polym. 2022 Nov 1;295:119825. doi: 10.1016/j.carbpol.2022.119825. Epub 2022 Jul 5.
9
Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor.生物工程肝素前体K5乙酰肝素的可控光化学解聚
Carbohydr Polym. 2011 Aug 1;86(3):1365-1370. doi: 10.1016/j.carbpol.2011.06.042.
10
Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.伯氏考克斯体β-葡糖苷酸酶 Bp 的特异性和作用模式。
Glycobiology. 2019 Jul 19;29(8):572-581. doi: 10.1093/glycob/cwz039.

引用本文的文献

1
Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy.多面肝素:抗凝治疗之外的多样应用
Pharmaceuticals (Basel). 2024 Oct 12;17(10):1362. doi: 10.3390/ph17101362.
2
Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing.肝素模拟物作为COVID-19的潜在干预手段及其生物制造
Synth Syst Biotechnol. 2023 Mar;8(1):11-19. doi: 10.1016/j.synbio.2022.10.002. Epub 2022 Oct 23.